Definición, etiología, factores de riesgo y fenotipos de la EPOC

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Archivos De Bronconeumologia

• Publication date

  2017-06-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/S0300-2896(17)30357-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Algorithm for identification of asthma–COPD overlap: consensus between the Spanish COPD and asthma guidelines

  2017cited by this paper
• Omalizumab Treatment Response in a Population With Severe Allergic Asthma and Overlapping COPD

  2017cited by this paper
• Clinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL study

  2017cited by this paper
• Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study

  2017cited by this paper
• Prevalence and etiological profile of chronic obstructive pulmonary disease in nonsmokers

  2017cited by this paper
• Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort.

  2016cited by this paper
• Asthma-like Features and Clinical Course of Chronic Obstructive Pulmonary Disease. An Analysis from the Hokkaido COPD Cohort Study.

  2016cited by this paper
• Distribution and Outcomes of a Phenotype-Based Approach to Guide COPD Management: Results from the CHAIN Cohort

  2016cited by this paper
• Comorbidome, Pattern, and Impact of Asthma-COPD Overlap Syndrome in Real Life.

  2016cited by this paper
• Omalizumab (anti-IgE) therapy in the asthma–COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels

  2016cited by this paper
• Understanding asthma-chronic obstructive pulmonary disease overlap syndrome.

  2016cited by this paper
• A comparison of the efficacy of once-daily fluticasone furoate/vilanterole with twice-daily fluticasone propionate/salmeterol in asthma-COPD overlap syndrome.

  2015cited by this paper
• GEMA4.0. Guía española para el manejo del asma

  2015cited by this paper
• Actualización sobre indicaciones de búsqueda activa de casos y tratamiento con alfa-1 antitripsina por vía intravenosa en pacientes con enfermedad pulmonar obstructiva crónica asociada a déficit de alfa-1 antitripsina

  2015cited by this paper
• Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.

  2015cited by this paper
• Frequency and characteristics of different clinical phenotypes of chronic obstructive pulmonary disease.

  2015cited by this paper
• Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease.

  2015influential reference
• Clinical characteristics of the asthma–COPD overlap syndrome – a systematic review

  2015cited by this paper
• Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study.

  2015cited by this paper
• The silent epidemic of COPD in Africa.

  2015cited by this paper
• Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients

  2015cited by this paper
• The Asthma-COPD Overlap Syndrome.

  2015cited by this paper
• Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD.

  2015cited by this paper
• The asthma–chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges

  2015cited by this paper
• Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis

  2015cited by this paper
• Prevalence of asthma–COPD overlap syndrome among primary care asthmatics with a smoking history: a cross-sectional study

  2015cited by this paper
• Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma.

  2014cited by this paper
• Disease associations in alpha-1-antitrypsin deficiency.

  2014cited by this paper
• Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke.

  2014cited by this paper
• Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems

  2014cited by this paper
• Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.

  2014cited by this paper
• Estudio, diagnóstico y propuesta de mejora del portal web del Ministerio de Sanidad, Servicios Sociales e Igualdad

  2014cited by this paper
• Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke.

  2014cited by this paper
• Inhaled corticosteroids in COPD and the risk of serious pneumonia

  2013cited by this paper
• The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations

  2013cited by this paper
• The Coexistence of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Prevalence and Risk Factors in Young, Middle-aged and Elderly People from the General Population

  2013cited by this paper
• La formulación de recomendaciones en salud: el sistema GRADE

  2013cited by this paper
• Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status.

  2013cited by this paper
• Calidad y fuerza: el sistema GRADE para la formulación de recomendaciones en las guías de práctica clínica

  2013cited by this paper
• Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD).

  2013cited by this paper
• The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age.

  2013cited by this paper
• Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.

  2012cited by this paper
• Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery.

  2012cited by this paper
• [Spanish COPD Guidelines (GesEPOC): Pharmacological treatment of stable COPD].

  2012cited by this paper
• Tiotropium in asthma poorly controlled with standard combination therapy.

  2012cited by this paper
• Fenotipos clínicos de la EPOC. Identificación, definición e implicaciones para las guías de tratamiento

  2012cited by this paper
• Guía de Práctica Clínica para el Diagnóstico y Tratamiento de Pacientes con Enfermedad Pulmonar Obstructiva Crónica (EPOC) - Guía Española de la EPOC (GesEPOC)

  2012cited by this paper
• Clinical Phenotypes of COPD: Identication, Denition and Implications for Guidelines

  2012cited by this paper
• Medical Utilization and Cost in Patients with Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Asthma

  2012cited by this paper
• Hacia un nuevo enfoque en el tratamiento de la EPOC. La Guía Española de la EPOC (GESEPOC)

  2011cited by this paper
• Chronic obstructive pulmonary disease and long-term exposure to traffic-related air pollution: a cohort study.

  2011cited by this paper
• Quantitative CT measures of emphysema and airway wall thickness are related to D(L)CO.

  2011cited by this paper
• Overlap Syndrome of Asthma and COPD Predicts Low Quality of Life

  2011cited by this paper
• The clinical features of the overlap between COPD and asthma

  2011cited by this paper
• Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes.

  2011cited by this paper
• Factors associated with bronchiectasis in patients with COPD.

  2011cited by this paper
• [Moving towards a new focus on COPD. The Spanish COPD Guidelines (GESEPOC)].

  2011cited by this paper
• Prior TB, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou Biobank Cohort Study.

  2010cited by this paper
• Predictive accuracy of patient-reported exacerbation frequency in COPD

  2010cited by this paper
• An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease.

  2010cited by this paper
• Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres

  2010cited by this paper
• Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes

  2010cited by this paper
• Susceptibility to exacerbation in chronic obstructive pulmonary disease.

  2010cited by this paper
• Risk of COPD from exposure to biomass smoke: a metaanalysis.

  2010cited by this paper
• Chronic obstructive pulmonary disease phenotypes: the future of COPD.

  2010influential reference
• Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease

  2010cited by this paper
• COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis

  2010cited by this paper
• Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities

  2009cited by this paper
• Targeted treatment in COPD: a multi-system approach for a multi-system disease

  2009cited by this paper
• Chronic obstructive pulmonary disease in non-smokers

  2009cited by this paper
• Screening for and early detection of chronic obstructive pulmonary disease.

  2009cited by this paper
• Variability and effects of bronchial colonisation in patients with moderate COPD

  2009cited by this paper
• Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis

  2009cited by this paper
• A 4-year trial of tiotropium in chronic obstructive pulmonary disease (UPLIFT trial).

  2009cited by this paper
• The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort.

  2009cited by this paper
• Impact of occupational exposure on severity of COPD.

  2008cited by this paper
• Incorporating considerations of resources use into grading recommendations

  2008cited by this paper
• Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease.

  2008cited by this paper
• Burden of concomitant asthma and COPD in a Medicaid population.

  2008cited by this paper
• Proportional classifications of COPD phenotypes

  2008cited by this paper
• Immunology of asthma and chronic obstructive pulmonary disease

  2008cited by this paper
• Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

  2008cited by this paper
• Alpha-1 antitrypsin deficiency: pathogenesis, clinical presentation, diagnosis, and treatment.

  2008cited by this paper
• A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

  2008cited by this paper
• Study of the impact of laws regulating tobacco consumption on the prevalence of passive smoking in Spain.

  2008cited by this paper
• Biomass fuels and respiratory diseases: a review of the evidence.

  2008cited by this paper
• Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America

  2007cited by this paper
• Occupational Causes of Chronic Obstructive Pulmonary Disease

  2007cited by this paper
• Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study.

  2007cited by this paper
• Cross-sectional and prospective associations between passive smoking and respiratory symptoms at the workplace.

  2007cited by this paper
• Tabaquismo parental y funcin pulmonar en nios y adolescentes sanos

  2007cited by this paper
• Global burden of COPD: risk factors, prevalence, and future trends.

  2007influential reference
• Developing COPD: a 25 year follow up study of the general population

  2006cited by this paper
• Wood smoke exposure and risk of chronic obstructive pulmonary disease

  2006cited by this paper
• Diagnóstico y tratamiento del déficit de alfa-1-antitripsina

  2006cited by this paper
• Guía Española para el Manejo del Asma (GEMA)

  2005cited by this paper
• Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease.

  2005cited by this paper
• The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom.

  2003cited by this paper
• Passive smoking and respiratory symptoms in the FinEsS Study

  2003cited by this paper
• Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.

  2003cited by this paper

• No citing papers are available for this paper.